Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

about

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

Item

http://www.wikidata.org/entity/Q58564259

description

scientific article published on 15 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@en

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@nl

type

Item

label

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@en

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@nl

prefLabel

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@en

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@nl

P1476

Combination Therapy with EpCAM ...... Human Colorectal Cancer Models

@en

P2093

Hailong Li

http://www.w3.org/2001/XMLSchema#string

Haixu Zhang

http://www.w3.org/2001/XMLSchema#string

Hongyan Liu

http://www.w3.org/2001/XMLSchema#string

Jiage Ding

http://www.w3.org/2001/XMLSchema#string

Mengmeng Lu

http://www.w3.org/2001/XMLSchema#string

Yangna Miao

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of drug resistance in colon cancer and its therapeutic strategies

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models

Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma.

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

P304

4263520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/4263520

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410941

http://www.w3.org/2001/XMLSchema#string

P921

immunology

colorectal cancer

P932

6205314

http://www.w3.org/2001/XMLSchema#string